Two years ago, Elaiapharm undertook the packaging of an important new solid dose product (Cipralex, an antidepressant) to be launched across a large number of international markets. The product itself is an ODT – orally dispersible tablet – formulation packed in child resistant cold form blisters. The blisters, unprinted at this stage, are manufacted by an external supplier and shipped to Elaiapharm stacked in magazines of 100 blisters each. The focused indication of the product requires packaging in relatively small lots with packaging components specific to each of the markets served. Furthermore, two product strengths and three different counts of blisters per carton must be considered. Elaiapharm sought a solution that would enable the timely and efficient blister printing and packaging of this complex portfolio.